Limitations of Acetaminophen as a Reference Hepatotoxin
Author Information
Author(s): Livoti Lucia A, Sison-Young Rowena, Reddyhoff Dennis, Fisher Ciarán P, Gardner Iain, Diaz-Nieto Rafael, Goldring Christopher E, Copple Ian M
Primary Institution: University of Liverpool
Hypothesis
Is acetaminophen an appropriate reference hepatotoxin for evaluating in vitro liver models?
Conclusion
Acetaminophen is not a suitable reference hepatotoxin for in vitro liver models due to the high concentrations required to induce cell death compared to clinical settings.
Supporting Evidence
- Acetaminophen concentrations required to induce cell death in vitro are much higher than those associated with clinical hepatotoxicity.
- The study used a CYP450 inhibitor to show that acetaminophen toxicity does not depend on metabolic bioactivation in primary hepatocytes.
- Recommendations were made for selecting alternative hepatotoxins for evaluating in vitro liver models.
Takeaway
This study found that using acetaminophen to test liver models isn't good because it takes much more of the drug in the lab than what would hurt people in real life.
Methodology
The study used primary hepatocytes from humans, mice, and rats to assess the effects of acetaminophen and the role of a CYP450 inhibitor.
Potential Biases
Potential bias in the selection of hepatotoxic compounds and the interpretation of in vitro results.
Limitations
The study primarily focuses on acetaminophen and does not explore other potential hepatotoxins in detail.
Participant Demographics
Human hepatocytes were obtained from patients undergoing liver resections.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website